Skip to main content

Table 3 Comparison of parameters before and after treatment in each group

From: Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients

 

Sevelamer (n = 23)

Calcium Carbonate (n = 27)

BT

AT

P

BT

AT

P

Ca (mg/dL)

9.37 ± 0.66

9.63 ± 0.80

0.038*

9.37 ± 0.73

10.17 ± 0.90

0.000*

P (mg/dL)

6.54 ± 0.91

5.07 ± 0.85

0.000*

7.22 ± 0.98

5.70 ± 1.01

0.000*

iPTH (pg/mL)

354.70 (332.70)

329.60 (319.80)

0.903

320.90 (371.8)

165.20 (405.60)

0.001*

ALK-P (IU/L)

82.17 ± 32.71

112.43 ± 43.21

0.004*

65.67 ± 23.70

64.41 ± 23.13

0.609

HsCRP (mg/L)

2.3 (5.8)

1.6 (3.1)

0.003*

3.10 (6.1)

1.9 (6.6)

0.866

Hct (%)

33.10 ± 3.87

32.80 ± 3.72

0.728

32.49 ± 3.11

32.49 ± 4.58

0.996

Albumin (g/L)

39.92 ± 3.13

39.96 ± 3.02

1.000

39.81 ± 2.86

40.78 ± 2.95

0.062

TG (mg/dL)

98.00 (86.00)

96.00 (103)

0.891

113.00 (127.00)

103.00 (65)

0.343

LDL-C (mg/dL)

108.96 ± 30.10

63.91 ± 20.55

0.000*

112.93 ± 33.46

105.19 ± 30.93

0.157

Fetuin-A (ug/mL)

210.61 (104.73)

153.85 (38.64)

0.003*

203.95 (107.87)

170.90 (58.02)

0.002*

  1. BT before treatment, AT after treatment
  2. Data are mean ± standard deviation or median (interquartile range, IQR)
  3. P < 0.05*
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us